HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s share price traded up 0.6% on Friday . The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares were traded during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Trading Up 0.6 %
The stock’s fifty day moving average price is $25.31 and its 200-day moving average price is $25.31.
About HemaCare
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Further Reading
- Five stocks we like better than HemaCare
- High Flyers: 3 Natural Gas Stocks for March 2022
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Want to Profit on the Downtrend? Downtrends, Explained.
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.